PBI18 EVALUATING THE BUDGET IMPACT OF PATISIRAN, THE FIRST...

Value in Health 2019 / 05 Vol. 22

PBI18 EVALUATING THE BUDGET IMPACT OF PATISIRAN, THE FIRST APPROVED RNAI THERAPEUTIC, FOR TREATING THE POLYNEUROPATHY OF HATTR AMYLOIDOSIS

Lin, H., Merkel, M., Pelligra, C., Shah, A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.101
Date:
May, 2019
File:
PDF, 317 KB
english, 2019
Conversion to is in progress
Conversion to is failed